Bayer launches jumbo rights issue as Monsanto deal closes

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Follow-ons and Rights issues

Bayer launches jumbo rights issue as Monsanto deal closes

Aidan Gregory
June 04, 2018 01:30 pm
Werner_Bauman_PA_230x150
25 may 2018, Germany, Bonn: Werner Baumann, CEO of Bayer, speaks at the general meeting of his company. Photo: Henning Kaiser/dpa | Henning Kaiser/DPA/PA Images

Bayer, the German life sciences company, this week unveiled the terms for a €6bn rights issue, after its acquisition of Monsanto, the US agrochemical and biotech company, cleared its final regulatory hurdles last week.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

GermanyEquityEuropeFollow-ons and Rights issuesEMEA
AG
Aidan Gregory
Gift this article